Pharmaceuticals Headlines from PR Newswire

< Go Back

Irvine Pharmaceutical Services Announces the Opening of an Analytical Facility in Hangzhou, China
Chugai licenses ISPRI/OptiMatrix platform from EpiVax for de-risking biologics
TNI BioTech, Inc., through its wholly owned subsidiary TNI BioTech International Ltd., announces start of a bridging trial in Nigeria for HIV/AIDS
AnaMar AB Reports Top-Line Results from Exploratory Phase 2a Study of AMAP102 and Provides Corporate Update
Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014
China Biologic to Report Third Quarter 2014 Financial Results
Protection Against Norovirus by Human-Milk-Oligosaccharides
Molecular Profiles To Launch US Strategic Alliance At AAPS
Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets
CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems
Report: Drugstore Chains Drive Retail Clinic Growth
Novocure™ Enrolls First Patient in a Pilot Study of Tumor Treating Fields (TTFields) Together with Paclitaxel for the Treatment of Recurrent Ovarian Cancer
ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA
Electronic Health Record Usability: CIOs Weigh In
Neurocrine Biosciences Receives Breakthrough Therapy Designation for NBI-98854 in Tardive Dyskinesia
WHEATON® Highlights Unique Products at AAPS 2014 Providing Purpose-Built Solutions for the Pharmaceutical Industry
Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference
Can-Fite to Participate in BIO-Europe International Partnering Conference
Omidria™ Granted Pass-Through Reimbursement Status from CMS
DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak
Experts Present Latest Research at Allergy Day
CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results
Pre-Filled Syringes Market and Digital Syringe Industry Forecasts in New Research Reports
TWi Pharmaceuticals Receives US FDA Approval on Generic Donepezil Hydrochloride Tablets USP, 23 mg, its fifth ANDA from US FDA
New Data on Fatigue from ROMANA 1, a Pivotal Phase III Study of Anamorelin in Advanced NSCLC Patients with Cachexia Presented at 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology
Kiadis Pharma's Lead Product ATIR™ Granted Orphan Drug Designation by EMA for the Treatment of Acute Myeloid Leukemia
Lilly Shares Insights from Decade-Long Technology Transfer Experience
BioMed Realty Trust Reports Third Quarter 2014 Financial Results
Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments
Hospital Stretchers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
CTI BioPharma Reports Third Quarter 2014 Financial Results
QIAGEN Reports Results for Third Quarter and First Nine Months of 2014
ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015
NeuroDerm Announces Positive Topline Results of Phase II, Placebo-Controlled Study of Continuous, Subcutaneously Delivered Levodopa/Carbidopa (ND0612L) in Patients with Moderate to Severe Parkinson's Disease
IBM and Cleveland Clinic Use Watson to Advance Genomic Research for Cancer Care Pilot English
U.S. Physicians and Payers are Generally Positive About the Efficacy of Pfizer's Xeljanz for Treating RA But They Have Mixed Views About Its Effect on Structural Damage and Safety
Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2015 On November 4, 2014
Novo Nordisk now hiring for new manufacturing facility in New Hampshire
Apollo Medical Holdings Launches Apollo Palliative Services With Acquisition Of Majority Stakes In Hospice And Home Health Companies
Neuland Labs Reports Second Quarter Fiscal Year 2015 Financial Results
IPRO Team Creates Drug Safety Tool For Care Transitions, Cites Improved Communications Regarding High Risk Medications
CSL Behring Announces Winners of its 13th Annual Gettin' in the Game(SM) Junior National Championship Program
"Lock-In" Program Could Solve Medicare Drug Fraud: NCPA
Abbott Expands Its Medical Device Business with Acquisition in Catheter-Based Electrophysiology Market English
JDRF-Funded Islet Encapsulation Program Reaches Historic Milestone
Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock
Lilly to Present Record-Breaking $12.7 Million Gift to United Way
Imprimis Pharmaceuticals Enters into License Agreement for Patented Urology Formulation
MEI Pharma Advances Clinical Study Of Mitochondrial Inhibitor ME-344 In Small Cell Lung And Ovarian Cancers

< Prev Next >
PR Newswire - United Business Media